- About
- People
- Research
- Education
- Industry
- Giving
- Ryan Fellows
- Kabiller Prize
- News
- Events
‹ back to news & updates
IIN Director Chad Mirkin, Exicure CEO David Giljohann discuss how SNAs are transforming drug delivery
EVANSTON, Ill.—International Institute for Nanotechnology (IIN) Director Chad Mirkin and David Giljohann, Northwestern professor and CEO of IIN-startup Exicure, Inc., discuss how spherical nucleic acids, or SNAs, developed at Northwestern, are transforming aspects of drug delivery and pharmaceutical development. Read the full article in Crain’s Chicago Business.
Leave a Reply Cancel reply
* Get an image next to your comment by visiting Gravatar.com and uploading a profile photo that links to your email address.
For Journalists
NORTHWESTERN MEDIA CONTACT
Megan Fellman
Science and Engineering Editor
Phone: 847-491-3115
Email: Megan Fellman
IIN MEDIA CONTACT
Sheryl Cash
Assoc. Director Marketing and Communications
Phone: 847-467-2530
Email: Sheryl Cash
Signup For Our Newsletter
Sign up for our newsletter to receive information on events, news, and articles.
More Info
No Comments
No comments yet.